Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
15009111000001105----1件: 43 💬
2[Glucocorticoids (GC)]----2件: 43, 44 💬
3[IFX-1]----2件: 43, 44 💬
4ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬 --21件: 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
5Avacopan1件: Avacopan1件: Avacopan 💬 1件: C5AR1 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬4件: 43, 44, 66, 223 💬
6Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--26件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
7BELIMUMAB1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬17件: 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
8Belimumab 10 mg/kg1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 43, 46, 49 💬
9Benlysta----7件: 43, 48, 49, 53, 63, 66, 222 💬
10Benlysta 400 mg powder for concentrate for solution for infusion----2件: 43, 49 💬
11Benlysta 400mg polvere per concentrato per soluzione per infusione----1件: 43 💬
12Blisibimod1件: Blisibimod1件: Blisibimod 💬 --5件: 43, 44, 49, 63, 66 💬
13CCX168----6件: 43, 44, 49, 66, 109, 223 💬
14CD19- BCMA CAR-T cells----4件: 43, 49, 51, 53 💬
15CELLCEPT----7件: 11, 13, 42, 43, 49, 222, 223 💬
16CellCept (Mycophenolate Mofetil)1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 42, 43 💬
17Chimeric monoclonal antibody, IgG4 subtype----2件: 43, 44 💬
18Corticosteroid----12件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
19Corticosteroid and azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--4件: 42, 43, 44, 45 💬
20Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
21Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		7件: Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate ,
Azathioprine sodium ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
22DELTACORTENE----2件: 43, 97 💬
23Dengue 1,2,3,4 (attenuated) vaccine----8件: 40, 43, 44, 46, 48, 49, 51, 107 💬
24Diagnostic Test: Procalcitonin-variants ELISA-Assay1件: Procalcitonin---2件: 43, 44 💬
25ENDOXAN BAXTER----3件: 13, 43, 96 💬
26GALEN® tablet----2件: 43, 44 💬
27Glucocorticoid (GC)----3件: 43, 44, 46 💬
28Glucocorticoids----13件: 35, 40, 41, 43, 44, 49, 60, 61, 62, 75, 96, 221, 300 💬
29Glucocorticoids (GC)----2件: 43, 44 💬
30Glucocorticoids - Reduced Dose----2件: 43, 44 💬
31Glucocorticoids - Standard Dose----2件: 43, 44 💬
32Glucocorticoids [Reduced Dose]----2件: 43, 44 💬
33Glucocorticoids [Standard Dose]----2件: 43, 44 💬
34Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
35Idefirix----3件: 43, 44, 113 💬
36IFX-11件: Vilobelimab1件: Vilobelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 43, 44, 269 💬
37Imlifidase1件: Imlifidase1件: Imlifidase 💬 --4件: 43, 44, 113, 221 💬
38Immunoglobulin G cleaving cystein protease derived from E. coli----2件: 43, 44 💬
39Infliximab1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
40Intravenous immunoglobulins (human immunoglobulins G)----1件: 43 💬
41Intravenous methyl prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
42Mabthera----20件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
43Mabthera®----7件: 13, 35, 43, 44, 46, 63, 93 💬
44MabThera® 100MG----1件: 43 💬
45MabThera® 500MG----1件: 43 💬
46Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
47Methyl prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 43, 49, 96 💬
48Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
49Methylprednisolone (or other glucocorticoid)1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
50Mycophenolate1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬4件: 43, 84, 162, 228 💬
51Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
52Mycophenolate mofetil,methotrexate2件: Methotrexate,
Mycophenolate mofetil		4件: Methotrexate ,
Mycophenolate mofetil ,
Methotrexate sodium ,
Mycophenolate mofetil hydrochloride 💬 		4件: DHFR,
DHFR2,
IMPDH1,
IMPDH2 💬 		5件: Drug metabolism - other enzymes, Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate, Purine metabolism 💬3件: 42, 43, 45 💬
53Mycophenolic acid1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬9件: 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
54Naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬14件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
55NALTREXONE HYDROCHLORIDE1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬9件: 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
56Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 43, 44, 49, 63, 222, 223 💬
57Other: Active Comparator----2件: 43, 44 💬
58Other: blood specimen----4件: 43, 96, 97, 329 💬
59Other: No Plasma Exchange----2件: 43, 44 💬
60Pednisone----2件: 43, 44 💬
61Plaquenil - Hydroxychloroquine 200mg Film coated tablets1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--3件: 43, 44, 45 💬
62Plasma exchange----7件: 13, 43, 44, 64, 95, 171, 222 💬
63PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
64Prednison acis® 20 mg----2件: 43, 44 💬
65Prednison acis® 5 mg----2件: 43, 44 💬
66Prednison acis¿ 20 mg----2件: 43, 44 💬
67Prednison acis¿ 5 mg----2件: 43, 44 💬
68Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
69Prednisone (and methylprednisolone)2件: Methylprednisolone,
Prednisone		3件: Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
70PredniSONE Tablets, USP1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44 💬
71Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		3件: Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
72Procalcitonin1件: Procalcitonin---3件: 43, 44, 299 💬
73Rapcabtagene autoleucel----5件: 43, 44, 46, 49, 51 💬
74RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
75Rituximab (Arm A)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 43, 44 💬
76Rituximab (Arm B)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 43, 44, 63 💬
77Rituximab (R)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 43, 44 💬
78RIXATHON 500mg----1件: 43 💬
79RO0452294/V01----2件: 43, 44 💬
80RO0452294/V02----3件: 35, 43, 44 💬
81Ro106-1443----1件: 43 💬
82SC291----2件: 43, 49 💬
83Sendoxan----2件: 13, 43 💬
84Standard of Care (SOC)----5件: 43, 44, 49, 85, 171 💬
85Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬26件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
86Vilobelimab1件: Vilobelimab1件: Vilobelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 43, 44, 269 💬
87Vitamin D1件: Vitamin D---26件: 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬